Skip to main content
logo
Pharmagreen Biotech Inc. (PHBI)
OTCMKTS · Delayed Price · Currency is USD
0.0007
-0.0001 (-6.67%)
Jul 27, 2026, 9:53 AM EST

Pharmagreen Biotech Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '26 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Market Capitalization
1304108
Market Cap Growth
-16.66%594.36%-90.92%-57.81%36.76%-94.87%
Enterprise Value
1315118
Last Close Price
0.000.000.000.010.030.08

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '26 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
PS Ratio
184.24817.39133.90---
PB Ratio
-0.23-0.89-0.18-2.43-6.19-2.61

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '26 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
EV/Sales Ratio
285.76907.68249.79---

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '26 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Debt / Equity Ratio
-0.15-0.11-0.17-0.19-0.16-0.24
Net Debt / Equity Ratio
-0.15-0.11-0.17-0.18-0.14-0.24
Net Debt / FCF Ratio
-10.66-12.67-5.03-0.77-1.19-1.16
Asset Turnover
0.030.030.02---
Inventory Turnover
0.200.20----
Quick Ratio
0.0000.000.000.010.00
Current Ratio
0.040.000.020.110.180.08
Return on Assets (ROA)
-139.13%-141.50%-179.26%-229.74%-147.17%-67.73%
Return on Capital Employed (ROCE)
10.10%8.20%22.70%62.80%45.50%16.70%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '26 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Earnings Yield
-40.91%-36.04%-141.69%-19.80%-43.24%-31.81%
FCF Yield
-5.96%-1.01%-18.39%-9.64%-1.97%-7.93%
Buyback Yield / Dilution
-28.47%-41.33%-15.55%-37.46%-257.86%-10.82%